Base de dados : HANSEN
Pesquisa : HANSENIASE DIMORFA/SANGUE [Descritor de assunto]
Referências encontradas : 12 [refinar]
Mostrando: 1 .. 12   no formato [Detalhado]

página 1 de 1

  1 / 12 HANSEN  
              next record last record
seleciona
para imprimir
Id:27299
Autor:Klatser, Paul R; Janson, Anneke M; Thole, Jelle E. R; Buhrer, Samira; Bos, Corinne; Soebono, Hardyanto; Vries, Rene R. P. de.
Título:Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-Typed leprosy patients and healthy controls.
Fonte:Int. J. Lepr;65(2):178-189, Jun. 1997. tab, graf.
Resumo:In our search for Mycobacterium leprae antigens that might specifically induce immunity or immunopathology, we have tested both humoral and cellular immune reactivity against purified recombinant M. leprae antigens in 29 paucibacillary (PB), 26 multibacillary (MB) leprosy patients, and 47 matched healthy contacts. The following M. leprae antigens were tested: 2L-1 (65L-1, GroEl-1), 2L-2 (65L-2, GroEl-2), 4L (SoDA), 43L, 10L (B) and 25L (Sra). The individuals were also typed for HLAD-RB1 and DQB1 in order to see whether leprosy status and/or immune reactivity to these antigens might be associated with certain HLA types. We also tested sera from another 48 patients before, during and after multidrug therapy (MDT) to study the relationship between antibody reactivity to recombinant M. leprae antigens and MDT. Antibody titers to the four recombinant M. leprae antigens tested and to D-BSA were higher in MB patients compared to PB patients and healthy controls, and declined with treatment. From a diagnostic or monitoring point of view none of the recombinant antigens seemed to be an improvement over D-BSA, mainly due to the lower sensitivity. IgG subclasses were measured in positive sera of untreated patients. These were mainly of the IgG1 and IgG3 subclasses, but subclass diversity was also observed and antigen dependent: all four subclasses could be detected against 10L (B), only IgG1 and IgG3 against 43L and only IgG1 against 25L and 2L-1. Cellular immune reactivity against the purified recombinant M. leprae antigens was measured in a lymphocyte stimulation test (LST). As for M. leprae, there was an inverse correlation between antibody and T-cell reactivity. However, the number of LST responders to recombinant antigens was much lower than to M. leprae. The 43L antigen was recognized most often (19%-24% of individuals tested) and more often than the 10L (B) antigen (10%-12%). No clear correlation was observed with leprosy type or protection and, in general, M. leprae nonresponders were also negative with recombinant antigens. Finally, we confirmed that HLA-DRB1*02 is associated with leprosy in this population, and we observed an association between DQB1*0601 and lepromatous leprosy. The number of positive individuals was too small to allow a meaningful analysis of the relationship between HLA type and immune reactivity. Although these data do not allow a conclusion as to one of these purified recombinant antigens being either protection or disease related, the antigen-dependent IgG subclass diversity warrants further study on antigen-specific qualitative differences in immune reactivity that may be relevant for the outcome of an infection with M. leprae. (AU)^ien.
Descritores:Hanseníase Dimorfa/sangue
Hanseníase Dimorfa/imunol
Hanseníase Virchowiana/sangue
Hanseníase Virchowiana/imunol
Hanseníase Tuberculóide/sangue
Hanseníase Tuberculóide/imunol
Localização:BR191.1


  2 / 12 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-pt
Id:25985
Autor:Belda, Walter.
Título:Tratamento do mal perfurante plantar com um extrato de sangue desproteinizado (Solcoseryl): primeiros resultados.
Fonte:Rev. bras. Leprol;33(1/4):61-67, jan.-dez. 1965. ^bilus.
Resumo:Após considerações gerais sobre a importância do problema do mal perfurante plantar como incapacidade f¡sica e sua gênese, o autor expõe as caracter¡sticas de um produto obtido do sangue de amimais jovens (Solcoseryl) e usado no tratamento desta complicação tardia de lepra. Em quatorze anos obtem doze curas com um m¡nimo de cinco e um máximo de 38 aplicações, e em dois casos obtem melhora evidente. Os resultados são ilustrados por fotografias anteriores e posteriores ao tratamento. Concluiu-se que, pela ação cicatrizante rápida, é de utilidade no tratamento, em regime ambulatorial, do mal perfurante plantar de origem leprótica. (AU)^ipt.
Descritores:Úlcera do Pé/sangue
Úlcera do Pé/cirurg
Hanseníase Dimorfa/sangue
Hanseníase Dimorfa/fisiopatol
Hanseníase Dimorfa/cirurg
Hanseníase Virchowiana/sangue
Hanseníase Virchowiana/fisiopatol
Hanseníase Virchowiana/cirurg
Hanseníase Tuberculóide/sangue
Hanseníase Tuberculóide/fisiopatol
Limites:Humanos
Masculino
Feminino
Adulto
Meia-Idade
Idoso
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/brasleprol/1965/PDF/v33n1-4/v33n1-4a07.pdf - pt.
Localização:BR191.1


  3 / 12 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:25409
Autor:Matthews, L. J; Trautman, J. R
Título:Clinical and serological profiles in leprosy
?-
Fonte:s.l; s.n; 1965. 4p p. tab.
Resumo:Numerous clinical and serological similarities exist between lepromatous and dimorphous leprosy and diseases od collagen, particularly lupus erythematosus and rheumatoid arthritis. The clinical manifestations include spontaneous skin-ulcerations, ischaemic necrosis, petechial and purpuric eruptions, vesicle and bulla formation, subcutaneous nodules, hepatosplenomegaly, migratory arthralgia and polyarthritis, bizarre skin lesions including butterfly facial rashes, and a general tendency toward exacerbations and remissions. Haematological findings include anaemia and the ocasional appearance of lupus cells.Positive serological findings include rheumatoid factors, circulating thyroglobulin antibodies, false positive serological tests for syphilis, and cold precipitable proteins (a consistent finding). Because of these similarities, the authors believe that leprosy is a disease which should be considered as a model for the study of hyperglobulinaemic states, especially the diseases of collagen. An important consideration is that, unlike these other diseases, the agent causing leprosy is known.
Descritores:HANSENIASE DIMORFA/sangue
HANSENIASE DIMORFA/diag
HANSENIASE VIRCHOWIANA/sangue
HANSENIASE VIRCHOWIANA/diag
SEROLOGIA/métodos
SEROLOGIA/estatíst
SEROLOGIA/tend
TIROGLOBULINA/anal
 TIROGLOBULINA/sangue
 SORODIAGNOSTICO DA SIFILIS
Limites:HUMANO
Localização:BR191.1; 01815/s


  4 / 12 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15770
Autor:Vaquero, N; Sato, I; Bruni, M; Yonadi, V; Ortiz, C; Welberlein, M
Título:Lepra indeterminada. Una fase de transición en la evolución de la enfermedad
?-
Fonte:s.l; s.n; 1998. 5 p. ilus, gra.
Descritores:HANSENIASE DIMORFA
HANSENIASE DIMORFA
HANSENIASE DIMORFA
HANSENIASE DIMORFA
REAÇAO EM CADEIA POR POLIMERASE
ARGENTINA
DIAGNOSTICO DIFERENCIAL
Localização:BR191.1; 08515/s


  5 / 12 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15035
Autor:Partida-Sanchez, S; Favila-Castillo, L; Pedraza-Sanchez, S; Gomez-Melgar, M; Saul, A; Estrada-Parra, S; Estrada-Garcia, I
Título:IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction in thalidomide treatment
..-
Fonte:s.l; s.n; 1998. 7 p. tab, graf.
Descritores:ADOLESCENCIA
ANTICORPOS ANTIBACTÉRIAS
ANTICORPOS ANTIBACTÉRIAS
INTERPRETAÇAO ESTATISTICA DE DADOS
ERITEMA NODOSO
INTERFERON TIPO II
INTERFERON TIPO II
LEPROSTATICOS
LEPROSTATICOS
LEPROSTATICOS
HANSENIASE DIMORFA
HANSENIASE DIMORFA
HANSENIASE TUBERCULOIDE
HANSENIASE TUBERCULOIDE
MYCOBACTERIUM LEPRAE
TALIDOMIDA
TALIDOMIDA
TALIDOMIDA
FATOR DE NECROSE TUMORAL/ME
IMUNOGLOBULINA M/BL/CL
FATOR DE NECROSE TUMORAL/*ME
Limites:ESTUDO COMPARATIVO
Localização:BR191.1; 07285/s


  6 / 12 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15023
Autor:Moubasher, Alaa El-Din A; Kamel, Neveen A; Zedan, Hatem; Raheem, Diaa El-Din Abdel
Título:Cytokines in leprosy, I. Serum cytokine profile in leprosy
..-
Fonte:s.l; s.n; 1998. 8 p. tab, graf.
Descritores:CITOCINAS
INTERFERON TIPO II
INTERLEUCINA-1
INTERLEUCINA-10
INTERLEUCINA-2
HANSENIASE
HANSENIASE DIMORFA
HANSENIASE LEPROMATOSA
HANSENIASE TUBERCULOIDE
RECEPTORES DA INTERLEUCINA 2
RECEPTORES DA INTERLEUCINA-2/BL
FATOR DE NECROSE TUMORAL/ME
Limites:ESTUDO COMPARATIVO
Localização:BR191.1; 07297/s


  7 / 12 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15004
Autor:Goulart, I. M. B; Mineo, J. R; Foss, N. T
Título:Production of transforming growth factor-beta 1(TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy
..-
Fonte:s.l; s.n; 2000. 5 p. tab, graf.
Descritores:HANSENIASE DIMORFA
HANSENIASE DIMORFA
HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
HANSENIASE TUBERCULOIDE
HANSENIASE TUBERCULOIDE
GLICOLIPIDIOS
GLICOLIPIDIOS
LIPOPOLISSACARIDIOS
LIPOPOLISSACARIDIOS
MONOCITOS
MONOCITOS
MONOCITOS
MYCOBACTERIUM LEPRAE
Localização:BR191.1; 07342/s


  8 / 12 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14135
Autor:Moubasher, Alaa El-Din A; Kamel, Neveen A; Zedan, Hatem; Raheem, Diaa El-Din Abdel
Título:Cytokines in leprosy, II. Effect of treatment on serum cytokines in leprosy
..-
Fonte:s.l; s.n; 1998. 6 p. tab, graf.
Descritores:HANSENIASE
HANSENIASE
HANSENIASE DIMORFA
HANSENIASE DIMORFA
HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
HANSENIASE TUBERCULOIDE
HANSENIASE TUBERCULOIDE
LEPROSTATICOS
LEPROSTATICOS
CORTICOSTEROIDES
CORTICOSTEROIDES
CLOFAZIMINA
CLOFAZIMINA
CITOCINAS
CITOCINAS
INTERLEUCINA-1
INTERLEUCINA-10
RECEPTORES DA INTERLEUCINA 2
RECEPTORES DA INTERLEUCINA 2
Localização:BR191.1; 07110/s


  9 / 12 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:13966
Autor:Sehgal, Virendra N; Bhattacharya, Sambit N; Chattopadhaya, Debasish; Saha, Kunal
Título:Tumor necrosis factor: status in reactions in leprosy before and after treatment
..-
Fonte:s.l; s.n; 1993. 4 p. tab, graf.
Descritores:ADMINISTRAÇAO ORAL
ANTIINFLAMATORIOS NAO ESTEROIDES
ANTIINFLAMATORIOS NAO ESTEROIDES
CLOROQUINA
CLOROQUINA
CLOROQUINA
CLOFAZIMINA
CLOFAZIMINA
ERITEMA NODOSO
ERITEMA NODOSO
HIPERSENSIBILIDADE TARDIA
HIPERSENSIBILIDADE TARDIA
LEPROSTATICOS
HANSENIASE DIMORFA
HANSENIASE DIMORFA
HANSENIASE TUBERCULOIDE
HANSENIASE TUBERCULOIDE
PREDNISOLONA
PREDNISOLONA
COMPRIMIDOS
FATOR DE NECROSE DE TUMOR
HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
Localização:BR191.1; 06612/s


  10 / 12 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:13446
Autor:Sarno, Euzenir Nunes; Grau, G. E; Vieira, L. M. M; Nery, J. A
Título:Serum levels of tumour necrosis factor-alpha and interleukin-1B during leprosy reactional states
..-
Fonte:s.l; s.n; 1991. 6 p. tab, graf.
Descritores:ADOLESCENCIA
ANTIBIOTICOS
ERITEMA NODOSO
ERITEMA NODOSO
INTERLEUCINA-1
HANSENIASE
HANSENIASE
HANSENIASE DIMORFA
HANSENIASE DIMORFA
HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
HANSENIASE TUBERCULOIDE
HANSENIASE TUBERCULOIDE
FATOR DE NECROSE DE TUMOR
Localização:BR191.1; 06303/s


  11 / 12 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:13387
Autor:Parida, Shreemanta K; Grau, Georges E; Zaheer, A. Ahmed; Mukherjee, Rama
Título:Serum tumor necrosis factor and interleukin 1 in leprosy and during lepra reactions
..-
Fonte:s.l; s.n; 1992. 5 p. ilus, tab, graf.
Descritores:ADOLESCENCIA
CRIANÇA
ENSAIO IMUNORADIOMÉTRICO
INTERLEUCINA-1
ANTIGENO DE MITSUDA
HANSENIASE
HANSENIASE DIMORFA
HANSENIASE LEPROMATOSA
HANSENIASE TUBERCULOIDE
FATOR DE NECROSE DE TUMOR
Localização:BR191.1; 06406/s


  12 / 12 HANSEN  
              first record previous record
seleciona
para imprimir
Id:13315
Autor:Shegal, Virendra N; Bhattacharya, Sambit N; Shah, Yashodhara; Sharma, Vinay K; Gupta, Chander K
Título:Reaction in leprosy: acute phase reactant response during and after remission
..-
Fonte:s.l; s.n; 1992. 3 p. tab.
Descritores:ADOLESCENCIA
PROTEINA C-REATIVA
ERITEMA NODOSO
ERITEMA NODOSO
HANSENIASE DIMORFA
HANSENIASE DIMORFA
HANSENIASE DIMORFA
HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
VALOR PREDITIVO DOS TESTES
TEMPO DE REAÇAO
INDUÇAO DE REMISSAO
ALFA 1-ANTITRIPSINA
Limites:ESTUDO COMPARATIVO
Localização:BR191.1; 06475/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information